ArticleCancers2021

Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era.

Chiara Burgaletto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.